Expanded Access for Apixaban

Expanded access Available Bristol-Myers Squibb

This is an expanded access designed to provide access to apixaban for eligible participants.

Evaluation	Drug	Modality	Dose	Route
Background	Apixaban	Small molecule	—	—

No indication recorded.